ERIN CANTU: Open Payments
NPI 1184274185 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$245 in 11 payments from 7 companies in 2025. Trend: 2023 $656 · 2024 $624 · 2025 $245
Food & beverage: $245
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $91 |
| ABBVIE INC. | 2 | $37 |
| Janssen Biotech, Inc. | 1 | $33 |
| UCB, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Biofrontera Inc. | 1 | $19 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, Bimzelx, TALTZ, SPEVIGO.
Industry payments across LA — which companies pay providers there.
